Try our Advanced Search for more refined results

Expert Analysis

Biosimilar Patent Litigation May Be On The Rise In 2020

By Joshua Whitehill and Michael Cottler (January 14, 2020, 1:24 PM EST) -- The Biologics Price Competition and Innovation Act, signed into law as part of the Affordable Care Act in March 2010, established an abbreviated regulatory pathway and unique litigation framework for biosimilars in the United States. As we begin the new year and approach 10 years since the law's enactment, it is worth a look back at the past year and trends over the past decade as we contemplate what may lie ahead in U.S. biosimilar litigation. ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!